Aim Exercise is both effective and cost-effective in improving the health and wellbeing of cancer patients. COSA recommends all people with cancer receive: 1) discussion about the role of exercise in cancer recovery, 2) recommendation to follow appropriate exercise guidelines, 3) referral to an Accredited Exercise Physiologist (AEP) or physiotherapist with experience in cancer care. However, fewer than 15% of people receive a referral to exercise during treatment. GenesisCare Oncology undertook an implementation initiative to improve their exercise service by: 1) incorporating an AEP into their care team and 2) establishing an opt-out referral system to provide all patients with an AEP appointment. While initial evaluations suggest the service can enrol a higher number of people receiving cancer treatment, the value of this service remains unclear. One major impediment to value assessment is the lack of data required to conduct an assessment and/or economic evaluation. This aim of this pragmatic, real-world feasibility study is to use a quadruple aim, value-based framework to identify the value elements of existing exercise oncology implementation at two sites in WA to support future value assessment.
Methods This value-based framework collects data via routine data collection, surveys and interviews on: 1) costs; 2) outcomes; 3) patient experience; 4) provider experience.
Results Data collection is ongoing:
Aims |
Value elements currently identified: in-house vs home-based exercise |
|
Costs |
i) infrastructure; equipment/materials; labour… |
ii) travel, health service utilisation |
Outcomes |
HRQoL, CV fitness, falls, fatigue, attendance |
|
Patient experience |
Social engagement, side effects, uncoordinated, fear, empowerment, finance, partner/family, communication, support, accessibility, convenience |
|
Provider experience |
Time, role, staffing, communication, infrastructure, uptake, compliance, adherence, risk |
Conclusions This value-based framework has the potential to inform the delivery of greater benefits for all stakeholders and better value (improved health outcomes and reduced costs) for the health system, contributing to the sustainability of exercise oncology.